Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130
2002 StandoutNobel
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
2006 Standout
Cost-Effectiveness of Vertebral Fracture Assessment to Detect Prevalent Vertebral Deformity and Select Postmenopausal Women With a Femoral Neck T-Score > −2.5 for Alendronate Therapy: A Modeling Study
2006
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Determinants of disease and disability in the elderly: The Rotterdam elderly study
1991
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Bone density at various sites for prediction of hip fractures
1993 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2008
What is polypharmacy? A systematic review of definitions
2017 Standout
UK clinical guideline for the prevention and treatment of osteoporosis
2017
A New Approach to the Development of Assessment Guidelines for Osteoporosis
2002
Osteoporosis
2019 Standout
Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis
2011
Diabetic retinopathy
2010 Standout
Myasthenia Gravis
2016 Standout
A reference standard for the description of osteoporosis
2007
Vitamin D and prevention of colorectal cancer
2005
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
2012
Calcium and Vitamin D in Sarcoidosis: How to Assess and Manage
2010
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Assessment in Medical Education
2007 Standout
Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)
2008
Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK
2008
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or Older
1997 Standout
Circulating biochemical markers of bone remodeling in uremic patients
1999
TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation
2009 Standout
Coping with complexity: educating for capability
2001
Obesity and cancer risk: the role of the insulin–IGF axis
2006
Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes
2008
Clinical Assessment of Bone Mass, Quality and Architecture
1999
Vitamin D Deficiency
2007 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Potential cost-effective use of spine radiographs to detect vertebral deformity and select osteopenic post-menopausal women for amino-bisphosphonate therapy
2005
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis
2000
Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective
2012
Osteoarthritis
2015 Standout
The cost-effectiveness of the treatment of high risk women with osteoporosis, hypertension and hyperlipidaemia in Sweden
2007
Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study
2004
Sarcoidosis
2013 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Do Men and Women Fracture Bones at Similar Bone Densities?
2000
Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories
2013 Standout
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
2010
Prevalence of Diabetic Retinopathy in Rural China: The Handan Eye Study
2009
Risk of Hip Fracture Derived from Relative Risks: An Analysis Applied to the Population of Sweden
2000
Ethnic Differences in Bone Health
2015
Polypharmacy Among the Elderly in a List-Patient System
2015
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
2008 StandoutNobel
Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies
2002
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Quality and performance measures in bone densitometry
2006
Prevalence and Risk of Polypharmacy among the Elderly in an Outpatient Setting
2010
Universal sample preparation method for proteome analysis
2009 Standout
Association between weight or body mass index and hand osteoarthritis: a systematic review
2009
Ten Year Probabilities of Osteoporotic Fractures According to BMD and Diagnostic Thresholds
2001
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
BMD, clinical risk factors and their combination for hip fracture prevention
2009
Assessment of fracture risk
2004
Quality and performance measures in bone densitometry
2006
Rosiglitazone Causes Bone Loss in Mice by Suppressing Osteoblast Differentiation and Bone Formation
2005
Cancer immunotherapy comes of age
2011 StandoutNature
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids
2006
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Growth in children with chronic renal failure on intermittent versus daily calcitriol
2003
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Polypharmacy and Food–Drug Interactions Among Older Persons: A Review
2012
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Relationship of Dietary Protein and Soy Isoflavones to Serum IGF-1 and IGF Binding Proteins in the Prostate Cancer Lifestyle Trial
2007
Morbidity and Mortality Risk Associated With an Overweight BMI in Older Men and Women
2007
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Adipocyte differentiation from the inside out
2006 Standout
Synthesis of 1,25-Dihydroxyvitamin D3 by Human Endothelial Cells Is Regulated by Inflammatory Cytokines
2002
The Assessment of Fracture Risk
2010
Inappropriate prescribing in older fallers presenting to an Irish emergency department
2013
Towards a diagnostic and therapeutic consensus in male osteoporosis
2011
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Structural and biomechanical basis of racial and sex differences in vertebral fragility in Chinese and Caucasians
2005
Polypharmacy in the Elderly
2011
The Morbidity and Mortality Associated With Overweight and Obesity in Adulthood
2009
Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis
2010
Osteoarthritis
2019 Standout
Epidemiology and outcomes of osteoporotic fractures
2002 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Chronic Kidney Disease
2016 Standout
Effect of withdrawal of hormone replacement therapy on bone mass and bone turnover: the OFELY study
2003
Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study
2008
Polypharmacy and falls in older people: Balancing evidence-based medicine against falls risk
2014
Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study
2001
Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age
2005
Incorporating adherence into health economic modelling of osteoporosis
2008
Relationship of Bone Turnover to Bone Density and Fractures
1997
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Meta-analysis: Vitamin D Compounds in Chronic Kidney Disease
2007
Considerations for Development of Surrogate Endpoints for Antifracture Efficacy of New Treatments in Osteoporosis: A Perspective
2008
Cost-Effectiveness of Alendronate Therapy for Osteopenic Postmenopausal Women
2005
Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study
2005
Is there Any Interest in Combining Treatments in Osteoporosis?
2005
Change in Bone Turnover and Hip, Non-Spine, and Vertebral Fracture in Alendronate-Treated Women: The Fracture Intervention Trial
2004
[Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].
1999
Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate
2003
Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores
2009
Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study
2003
Relationship Between Changes in Biochemical Markers of Bone Turnover and BMD to Predict Vertebral Fracture Risk
2004
Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study
2000
Retinal Vascular Changes in Pre-Diabetes and Prehypertension
2007
An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women
2010
Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women
2004
Long-term fracture prediction by bone mineral assessed at different skeletal sites
1993
Transforming Growth Factor-β1 to the Bone
2005
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
1996
[A FRAX model for the assessment of fracture probability in Belgium].
2009
Type I Collagen Racemization and Isomerization and the Risk of Fracture in Postmenopausal Women: The OFELY Prospective Study
2002
Biochemical markers of bone turnover in osteoporosis.
1997
Vitamin D compounds for people with chronic kidney disease requiring dialysis
2009
Risk Factors for Hip Fracture in White Women
1995 Standout
Comparisons of Noninvasive Bone Mineral Measurements in Assessing Age-Related Loss, Fracture Discrimination, and Diagnostic Classification
1997
Proteomic profiling of differentiating osteoblasts
2006
Hip Fracture Prediction in Elderly Men and Women: Validation in the Rotterdam Study
1998
Bone Density and Fracture Risk in Men
1998
Racial bias in pain assessment and treatment recommendations, and false beliefs about biological differences between blacks and whites
2016 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Age-related decrements in bone mineral density in women over 65
1992
Assessing Bone Density in Men
2000
Common Carotid Intima-Media Thickness and Risk of Stroke and Myocardial Infarction
1997 Standout
Intracapsular Hip Fracture and the Region-Specific Loss of Cortical Bone: Analysis by Peripheral Quantitative Computed Tomography
2001
Association between osteoarthritis and cardiovascular disease: Systematic review and meta-analysis
2015
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of H.A.P. Pols being referenced
Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study
2007
Body mass index as a predictor of fracture risk: A meta-analysis
2005
The Effects of Lifestyle, Dietary Dairy Intake and Diabetes on Bone Density and Vertebral Deformity Prevalence: The EVOS Study
2001
A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids
2005
Polypharmacy and falls in the middle age and elderly population
2005
Basic science and clinical utility of biochemical markers of bone turnover — A congress report*
2009
Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
2000
Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam study
1996
Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study: Table 1
1996
Treatment of post‐menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial
1995
Bone density and risk of hip fracture in men and women: cross sectional analysis
1997
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam Study
1995
Noninvasive axial and peripheral assessment of bone mineral content: A comparison between osteoporotic women and normal subjects
1989
Effects of 24r,25-dihydroxyvitamin D3 in combination with 1α-hydroxyvitamin D3 in predialysis renal insufficiency: Biochemistry and histomorphometry of cancellous bone
1995
Retinopathy, Glucose, and Insulin in an Elderly Population: The Rotterdam Study
1995
Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate
1994
Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal women
1999
Biochemical markers of bone turnover: an update.
1994
Osteoblast Differentiation and Control by Vitamin D and Vitamin D Metabolites
2004
Circulating Free Insulin-Like Growth Factor (IGF)-I , Total IGF-I, and IGF Binding Protein-3 Levels Do Not Predict the Future Risk to Develop Prostate Cancer: Results of a Case-Control Study Involving 201 Patients within a Population-Based Screening with a 4-Year Interval
2004